comparemela.com

Latest Breaking News On - Provet pharma - Page 1 : comparemela.com

N+1 Capital To Close $100 Mn Maiden Fund By September 2022

Revenue-based growth capital firm N+1 Capital has announced that it will close its maiden fund for HNIs and family offices by September 2022.

Delhi
India
Rahul-chowdhury
Ashish-singla
Provet-pharma
Clensta-tech
Teamonk-global
Get-vantage

Provet Pharma Private Limited Raises Fund from N+1 Capital

Provet Pharma Private Limited, headquartered in Chennai, one of the fast-growing animal health care companies in India, raises an undisclosed amount from N1 Capital, one of Indias largest revenue-based growth capital funds. Founded in 2009, Provet Pharma manufactures and markets feed additivessupplements and drugs for poultry, livestock and aquaculture segments in India including exports under its own brands.

India
Chennai
Tamil-nadu
Devansh-shah
Muthu-selvan
Provet-pharma-private
Indian-animal-health-care
Provet-pharma-private-limited
Bilanz-capital-advisors
Provet-pharma
Animal-healthcare
Managing-director

Provet Pharma Private Limited Raises Fund from N+1 Capital

Chennai (Tamil Nadu) [India], March 21 (ANI/NewsVoir): Provet Pharma Private Limited, headquartered in Chennai, one of the fast-growing animal health care companies in India, raised an undisclosed amount from N+1 Capital, one of India s largest revenue-based growth capital funds

India
Chennai
Tamil-nadu
Devansh-shah
Muthu-selvan
Provet-pharma-private
Indian-animal-health-care
Provet-pharma-private-limited
Bilanz-capital-advisors
Provet-pharma
Animal-healthcare
Managing-director

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.